AN2 Therapeutics, Inc.: Form 8-K, filed Sep 8, 2023
Filed with the SEC on Sep 8, 2023 and accepted by EDGAR at Sep 7, 2023, 17:37 ET.
Items reported
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-23-230786. Last ingested by Listed: Nov 9, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.